Representative Matter
On July 1, 2025, Extendicare Inc. (TSX: EXE) completed its acquisition of all the issued and outstanding shares of Closing the Gap Healthcare Group ...
July 01, 2025
Representative Matter
On April 8, 2024, The Stevens Company Limited (The Stevens Company), a medical products distributor and equipment services provider based in Brampt ...
April 08, 2024
Representative Matter
CanAm Scientific, a global leader in technology, supply and manufacturing, has signed an exclusive agreement with Clemenceau Medical Center Hospita ...
October 26, 2023
Representative Matter
On June 29, 2023, Stonebridge Financial Corporation closed a long-term, fixed rate debt financing for Crown Ridge Health Care Services Inc.
June 29, 2023
Representative Matter
Represented Cybin Inc., a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of a US$30-million common share ...
May 30, 2023
Representative Matter
Juno Pharmaceuticals Corp., a leader in the commercialization of specialty pharmaceutical products, announced its acquisition of Omega Laboratories.
May 18, 2023
Representative Matter
On June 27, 2022, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF), a vertically integrated and federally licensed Canadian cannabis company, closed its ...
July 26, 2022
Representative Matter
Juno Pharmaceuticals Corp., a Canadian specialty generics pharmaceuticals company, announced that it had received a strategic growth investment fro ...
February 25, 2022
Representative Matter
On February 14, 2022, SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision ...
February 23, 2022
Representative Matter
Biomind Labs Inc. (formerly Crosswinds Holdings Inc.), completed a plan of merger under the BVI Business Companies Act 2004 (British Virgin Islands ...
September 23, 2021
Representative Matter
Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of an overnight marketed offerin ...
August 03, 2021
Representative Matter
Aird & Berlis acted as Canadian legal counsel to Small Pharma with a team that included Richard Kimel, Melanie Cole, Danny Kharazmi, Sean Green (Ca ...
May 03, 2021
Representative Matter
Aird & Berlis represented PsyBio Therapeutics, Inc. in a reverse takeover transaction and $14.5 million private placement.
February 19, 2021
Representative Matter
Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of a bought deal short form pros ...
February 04, 2021
Representative Matter
Aird & Berlis advised the shareholders of Bloombox Club, a privately-held e-commerce company that sells and delivers indoor plants and natural prod ...
December 21, 2020
Representative Matter
Represented Cybin Inc. (the “Company”) (NEO: CYBN) in the completion of its reverse takeover of Clarmin Explorations Inc. pursuant to the terms of ...
November 05, 2020
Representative Matter
Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer, in connecti ...
June 11, 2020
Representative Matter
Aird & Berlis is providing a wide range of ongoing advice to a ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discover ...
May 01, 2020
Representative Matter
Aird & Berlis represented a leading Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer in connection w ...
April 29, 2020
Representative Matter
Aird & Berlis represented a leading alternative medicine business incubator, IP aggregator and solutions provider in connection with its acquisitio ...
April 29, 2020